Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation

American Journal of Pathology

Volumn 176, Issue 6, 2010, Pages 3073-3084

  Bot, Martine ^a   Bot, Ilze ^a   Lopez Vales, Rubén ^b,c   Van De Lest, Chris H A ^d,e   Saulnier Blache, Jean Sébastien ^f   Helms, J Bernd ^d   David, Samuel ^b   Van Berkel, Theo J C ^a   Biessen, Erik A L ^a,g  

^a LEIDEN UNIVERSITY   (Netherlands)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f INSERM   (France)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; RNA; 2-ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2 GROUP VI;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL; CAROTID ARTERIOGRAPHY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME SYNTHESIS; HOMEOSTASIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RNA EXTRACTION; RNA ISOLATION; THROMBOGENICITY; UPREGULATION; ANIMAL; ATHEROSCLEROSIS; CAROTID ARTERY; CHEMISTRY; DIET; GENE EXPRESSION PROFILING; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

ACYLTRANSFERASES; ANIMALS; ATHEROSCLEROSIS; CAROTID ARTERIES; DIET; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GROUP VI PHOSPHOLIPASES A2; HOMEOSTASIS; HUMANS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; RECEPTORS, LDL;

EID: 77953186516     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090009     Document Type: Article

References (46)

1. Ross R: Atherosclerosis, an inflammatory disease. N Engl J Med 1999, 340:115-126
2. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372 (Pubitemid 32666962)
3. Shah PK: Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003, 41:15S-22S.
4. Falk E: Why do plaques rupture? Circulation 1992, 86:III30 -III42
5. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M: Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A 1999, 96:6931-6936
6. Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W: Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 2003, 108:741-747
7. Siess W, Tigyi G: Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 2004, 92:1086-1094
8. Moolenaar WH: Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 1995, 270:12949-12952
9. Moolenaar WH: Lysophosphatidic acid signalling. Curr Opin Cell Biol 1995, 7:203-210
10. Moolenaar WH, Kranenburg O, Postma FR, Zondag GC: Lysophosphatidic acid: g-protein signaling and cellular responses. Curr Opin Cell Biol 1997, 9:168-173
11. Rizza C, Leitinger N, Yue J, Fischer DJ, Wang DA, Shih PT, Lee H, Tigyi G, Berliner JA: Lysophosphatidic acid as a regulator of endothelial/ leukocyte interaction. Lab Invest 1999, 79:1227-1235 (Pubitemid 29489447)
12. Gennero I, Xuereb JM, Simon MF, Girolami JP, Bascands JL, Chap H, Boneu B, Sie P: Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture. Thromb Res 1999, 94:317-326
13. Natarajan V, Scribner WM, Hart CM, Parthasarathy S: Oxidized low density lipoprotein mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res 1995, 36:2005-2016
14. Siess W: Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002, 1582:204-215
15. Goetzl EJ, An S: Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J 1998, 12:1589-1598
16. Noguchi K, Ishii S, Shimizu T: Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 2003, 278:25600-25606
17. Kotarsky K, Boketoft A, Bristulf J, Nilsson NE, Norberg A, Hansson S, Owman C, Sillard R, Leeb-Lundberg LM, Olde B: Lysophosphatidic Acid Binds to and Activates GPR92, a G Protein-Coupled Receptor Highly Expressed in Gastrointestinal Lymphocytes. J Pharmaco Exp Ther 2006, 318:619-628
18. Gobeil F Jr., Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM, Checchin D, Sennlaub F, Hou X, Nader M, Bkaily G, Ribeiro-da-Silva A, Goetzl EJ, Chemtob S: Modulation of Pro-inflammatory Gene Expression by Nuclear Lysophosphatidic Acid Receptor Type-1. J Biol Chem 2003, 278:37875-38883
19. Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, Johnson LR, Marathe GK, McIntyre TM, Xu Y, Prestwich GD, Byun HS, Bittman R, Tigyi G: Lysophosphatidic acid induces neointima formation through PPARgamma activation. J Exp Med 2004, 199:763-774
20. Siess W: Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein. Pathophysiol Haemost Thromb 2006, 35:292-304
21. Gustafsson M, Levin M, Skålén K, Perman J, Fridén V, Jirholt P, Olofsson SO, Fazio S, Linton MF, Semenkovich CF, Olivecrona G, Borén J: Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ Res 2007, 101:777-783
22. Guyton JR: Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins: a mechanism for atherogenic lipid accumulation. Arterioscler Thromb Vasc Biol 2001, 21:884-886
23. von der Thüsen JH, van Berkel TJC, Biessen EAL: Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 2001, 103:1164-1170
24. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Med Sci 1959, 37:911-917
25. Bjerve KS, Daae LN, Bremer J: The selective loss of lysophospholipids in some commonly used lipid-extraction procedures. Anal Biochem 1974, 58:238-245
26. Bremer J: Carnitine in intermediary metabolism. The biosynthesis of palmitylcarnitine by cell subfraction J Biol Chem 1963, 238:2774-2779
27. Saulnier-Blache JS, Girard A, Simon MF, Lafontan M, Valet P: A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res 2000, 41:1947-1951 (Pubitemid 32038989)
28. Retra K, Bleijerveld OB, Van Gestel RA, Tielens AGM, Van Hellemond JJ, Brouwers JF: A simple and universal method for the separation and identification of phospholipid molecular species. Rapid Communications in Mass Spectrometry 2008, 22:1853-1862
29. 't Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J: Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 2003, 93:262-269
30. Olofsson KE, Andersson L, Nilsson J, Björkbacka H: Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun 2008, 370:348-352
31. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, Kishimoto T, Mizuno K, Saku K, Taguchi R, Arai H: Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 2002, 277:48737-48744
32. Tokumura A, Kanaya Y, Kitahara M, Miyake M, Yoshioka Y, Fukuzawa K: Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits. J Lipid Res 2002, 43:307-315 (Pubitemid 34184018)
33. Pickard RT, Strifler BA, Kramer RM, Sharp JD: Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2. J Biol Chem 1999, 274:8823-8831
34. Pages C, Simon MF, Valet P, Saulnier-Blache JS: Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat 2001, 64:1-10
35. 2 contains eight ankyrin motifs. J Biol Chem 1997, 272:8567-8575
36. Ren J, Xiao Y, Singh LS, Zhao X, Zhao Z, Feng L, Rose TM, Prestwich GD, Xu Y: Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res 2006, 66:3001-3014
37. Pilane CM, LaBelle EF: Arachidonic acid release by cPLA2 may be causally related to NO-induced apoptosis in vascular smooth muscle cells. J Cell Physiol 2002, 191:191-197
38. Panini SR, Yang L, Rusinol AE, Sinensky MS, Bonventre JV, Leslie CC: Arachidonate metabolism and the signaling pathway of induction of apoptosis by oxidized LDL/oxysterol. J Lipid Res 2001, 42:1678-1686 (Pubitemid 33020101)
39. Tigyi G, Parrill AL: Molecular mechanism of lysophosphatidic acid action. Prog Lipid Res 2003, 42:498-526
40. Puddu P, Puddu GM, Muscari A: Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression? Int J Cardiol 2003, 90:133-140
41. Boord JB, Fazio S, Linton MF: Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 2002, 13:141-147
42. Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, Storch J, Feinberg MW, Hsieh CM, Haber E, Lee ME: Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J 2001, 15:1774-1776
43. Layne MD, Patel A, Chen YH, Rebel VI, Carvajal IM, Pellacani A, Ith B, Zhao D, Schreiber BM, Yet SF, Lee ME, Storch J, Perrella MA: Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J 2001, 15:2733-2735
44. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS: The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities J Biol Chem 2005, 280:12888-12895
45. St John LC, Bell FP: Arterial fatty acid-binding protein activity associated with dietarily-induced and spontaneously occurring atherosclerosis in the rabbit (Oryctolagus cuniculus). Comp Biochem Physiol B 1990, 97:123-127
46. St John LC, Bell FP: Temporal evaluation of fatty acid-binding protein (FABP) activity in association with the development of atherosclerosis in the rabbit. Comp Biochem Physiol 1992, 102:357-361